Diffusibility of the newer cephalosporins into human interstitial fluids
- PMID: 6093516
Diffusibility of the newer cephalosporins into human interstitial fluids
Abstract
A skin window technique was used to investigate the ability of three of the newer cephalosporins, moxalactam, cefoperazone, and ceftriaxone, to enter the interstitial fluid of normal, healthy volunteers. Intravenous and intramuscular routes of delivery were compared. The method of delivery did not greatly affect diffusibility with moxalactam and ceftriaxone. Intravenous infusion resulted in greater diffusibility with cefoperazone than did intramuscular injection. Cefoperazone demonstrated the lowest diffusibility of the three test drugs. Ceftriaxone, administered at one-half the dose of cefoperazone and moxalactam, demonstrated the greatest ability to diffuse into interstitial fluid despite its high level of binding to plasma protein. The better diffusibility of ceftriaxone may be explained by a persistently high concentration gradient provided by its long serum half-life. Overall, the results support the concept of the concentration gradient as an important determinant of antibiotic activity.
Similar articles
-
Entry of four cephalosporins into the ovine lung.J Infect Dis. 1984 Feb;149(2):264-70. doi: 10.1093/infdis/149.2.264. J Infect Dis. 1984. PMID: 6321609
-
Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?Drugs. 1985 Sep;30(3):175-81. doi: 10.2165/00003495-198530030-00001. Drugs. 1985. PMID: 3899596 No abstract available.
-
Comparative study on the interstitial passage of cefuroxime, cefoxitin, cefotaxime and cefoperazone in man by the suction skin blister method.Boll Ist Sieroter Milan. 1983 Nov 30;62(5):412-6. Boll Ist Sieroter Milan. 1983. PMID: 6322818
-
Third-generation cephalosporins: a critical evaluation.Clin Pharm. 1984 Jul-Aug;3(4):351-73. Clin Pharm. 1984. PMID: 6432420 Review.
-
Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.Pediatr Infect Dis. 1985 Mar-Apr;4(2):188-91. Pediatr Infect Dis. 1985. PMID: 3885182 Review. No abstract available.
Cited by
-
Pharmacokinetics of intravenous cefmetazole with emphasis on comparison between predicted theoretical levels in tissue and actual skin window fluid levels.Antimicrob Agents Chemother. 1989 Jun;33(6):924-7. doi: 10.1128/AAC.33.6.924. Antimicrob Agents Chemother. 1989. PMID: 2764542 Free PMC article.
-
Clinical pharmacokinetics of ceftriaxone.Clin Pharmacokinet. 1989 Oct;17(4):223-35. doi: 10.2165/00003088-198917040-00002. Clin Pharmacokinet. 1989. PMID: 2686882 Review.
-
Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.Antimicrob Agents Chemother. 1990 Jun;34(6):1094-9. doi: 10.1128/AAC.34.6.1094. Antimicrob Agents Chemother. 1990. PMID: 2393268 Free PMC article. Clinical Trial.
-
Ion pair high-performance liquid chromatographic assay for ceftriaxone.Antimicrob Agents Chemother. 1987 Mar;31(3):385-8. doi: 10.1128/AAC.31.3.385. Antimicrob Agents Chemother. 1987. PMID: 3579254 Free PMC article.